CTGL — Citrine Global Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.10m
- $2.28m
Annual income statement for Citrine Global, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.251 | 0.149 | 0.011 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0.033 | -0.009 | -0.002 | 0 | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2.38 | 1.98 | 8.33 | 3.96 | 1.99 |
| Operating Profit | -2.13 | -1.84 | -8.32 | -3.96 | -1.99 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.16 | -1.87 | -8.64 | -4.52 | -2.65 |
| Net Income After Taxes | -2.16 | -1.87 | -8.64 | -4.52 | -2.65 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.16 | -1.87 | -8.64 | -4.52 | -2.65 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.16 | -1.87 | -8.64 | -4.52 | -2.65 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.066 | -0.045 | -0.018 | -0.004 | -0.003 |